Choroidal Volume
Showing 1 - 25 of 7,072
Circadian Macular Volume Changes in the Choroid
Completed
- Choroid Physiology
-
Graz, Styria, AustriaDepartment of Ophthalmology, Medical University of Graz
Sep 1, 2020
Tirofiban Plus Intravenous Thrombolysis in Acute Anterior
Not yet recruiting
- Acute Anterior Choroidal Infarction (ACI)
- Paramedian Pontine Infarction (IPP)
- IVT with tenecteplase or alteplase
- Intervention Name : Tirofiban and IVT with tenecteplase or alteplase
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Feb 17, 2023
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Diabetic Maculopathy Trial in Winston-Salem (Spironolactone 50 mg)
Withdrawn
- Diabetic Maculopathy
- Spironolactone 50 mg
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Jul 28, 2022
Macular Degeneration, Retinal Drusen Trial in Palo Alto (Pascal Retinal Laser Photocoagulator)
Completed
- Macular Degeneration
- Retinal Drusen
- Pascal Retinal Laser Photocoagulator
-
Palo Alto, CaliforniaByers Eye Institute at Stanford University
Oct 13, 2021
Non Exudative AMD Imaged With SS-OCT- Extension
Recruiting
- Dry Macular Degeneration
- SS-OCT imaging
-
Los Angeles, California
- +4 more
Mar 8, 2022
Non Exudative AMD Imaged With SS-OCT
Active, not recruiting
- Dry Macular Degeneration
- SS-OCT imaging
-
Los Angeles, California
- +4 more
Mar 8, 2022
Melanoma Trial in Nice (Protontherapy)
Terminated
- Melanoma
- Protontherapy
-
Nice, FranceCentre Antoine Lacassagne
Dec 12, 2022
Blood Pressure on Retinal Capillary Rarefaction in Arterial
Recruiting
- Arterial Hypertension
- Blood Pressure, High
-
Vienna, AustriaMedical University of Vienna
Oct 19, 2023
Diabetes, Type 2, Diabetic Retinopathy Trial (RLRL device)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- RLRL device
- (no location specified)
Mar 19, 2023
Optical Coherence Tomography And NEphropathy: The OCTANE Study
Recruiting
- Health
- +2 more
-
Edinburgh, Midlothian, United KingdomUniversity of Edinburgh
Apr 9, 2021
Myopia, Myopia Progression, Juvenile Myopia Trial in Waterloo (Diffusion Optics Technology (DOT) Pattern Spectacle Lens, Control
Not yet recruiting
- Myopia
- +2 more
- Diffusion Optics Technology (DOT) Pattern Spectacle Lens
- Control Spectacle Lens
-
Waterloo, Ontario, CanadaCentre for Ocular Research and Education
Dec 5, 2022
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +10 more
Mar 21, 2022
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal
Recruiting
- Choroidal Melanoma
- +3 more
- Belzupacap Sarotalocan
- +5 more
-
Birmingham, Alabama
- +32 more
Aug 23, 2023
Pachychoroid Neovasculopathy Trial (Three monthly injections of intravitreal aflibercept)
Not yet recruiting
- Pachychoroid Neovasculopathy
- Three monthly injections of intravitreal aflibercept
- (no location specified)
Dec 14, 2022
OCT Angiography in Wet AMD
Recruiting
- Neovascular (Wet) Age-related Macular Degeneration (AMD)
- Optical Coherence Tomography
-
Portland, OregonCasey Eye Institute, Oregon Health & Science University
Sep 20, 2022
Retinal and Choroidal Microvascular Parameters in
Completed
- COVID-19 Pandemic
-
Guangzhou, Guangdong, ChinaGuangzhou First People's Hospital
Jul 18, 2023
Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)
Completed
- Pathologic Myopia
- Intravitreal injection
-
Mykolaiv, Ukraine
- +2 more
Jan 23, 2023
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023
Choroid, Retina Trial (repeated low level light device (Eyerising [Suzhou Xuanjia Optoelectronics Technology))
Not yet recruiting
- Choroid
- Retina
- repeated low level light device (Eyerising [Suzhou Xuanjia Optoelectronics Technology)
- (no location specified)
Apr 3, 2023
Optical Coherence Tomography Angiography and Choroidal Osteoma
Completed
- Choroidal Osteoma, Bilateral
- Optical coherence tomography angiography
-
Naples, Napoli, ItalyFederico II University
Apr 16, 2022
Radiation Retinopathy, Visual Impairment Trial (Faricimab, fluocinolone acetonide)
Not yet recruiting
- Radiation Retinopathy
- Visual Impairment
- Faricimab
- fluocinolone acetonide
- (no location specified)
Apr 25, 2023
Choroid, Retina Trial in Foshan (RLRL device)
Not yet recruiting
- Choroid
- Retina
- RLRL device
-
Foshan, Guangdong, ChinaThe Second People's Hospital of Foshan
Feb 17, 2023
SWIDINEP a Swiss Diabetic Nephropathy Cohort
Active, not recruiting
- Diabetic Nephropathy
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois
Aug 4, 2021